All the statements are True regarding Selexipag except?
Correct Answer: Selective IP receptor antagonist
Description: Selexipag is an orally active, Selective IP receptor agonist(Prostacyclin Receptor Agonist) . Selexipag has shown to reduce Morbidity and Moality in patients with Pulmonary HT . A/E : similar to those of PGI2 analogues and include headache, jaw pain, nausea, dizziness, flushing, nasopharyngitis and vomiting. Adverse effects appear to be more common when the drug is taken while fasting . MOA :
Category:
Pharmacology
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now